Bottom line
How much do DLHIX and RYHIX overlap?
43% of their top holdings overlap by weight. 11 securities appear in both funds' top 25, making up 35.8% of DLHIX's assets and 18.7% of RYHIX's. They share a meaningful core but differ in the rest of the portfolio.
Updated Nov 22, 2026
Overlap at a glance
Holdings DLHIX and RYHIX have in common
| Holding | % of DLHIX | % of RYHIX | Overlap |
|---|---|---|---|
| Abbvie Inc ABBV | 4.19% | 2.52% | 2.52% |
| Eli Lilly & Company LLY | 4.16% | 3.63% | 3.63% |
| Regeneron Pharmaceuticals Inc REGN | 3.91% | 0.90% | 0.90% |
| Unitedhealth Group Inc UNH | 3.88% | 2.22% | 2.22% |
| Pfizer Inc PFE | 3.84% | 1.25% | 1.25% |
| Merck & Company Inc MRK | 3.68% | 2.04% | 2.04% |
| Gilead Sciences Inc GILD | 3.54% | 1.39% | 1.39% |
| Elevance Health Inc ELV | 3.25% | 1.02% | 1.02% |
| Amgen Inc AMGN | 2.27% | 1.56% | 1.56% |
| Vertex Pharmaceuticals Inc VRTX | 1.66% | 1.34% | 1.34% |
| Boston Scientific Corp BSX | 1.42% | 0.86% | 0.86% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Free weekly newsletter
The Fund Letter
Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.
Free. Unsubscribe anytime. We never sell your email.
What each fund holds that the other doesn't
Top-25 holdings that appear in only one of the two funds' top 25.
Only in DLHIX
- Ucb Sa — 5.19%
- Astrazeneca Plc — 3.27%
- Roche Holding Ag — 3.01%
- Chugai Pharmaceutical Co Ltd — 2.77%
- Viatris Inc — 2.48%
- Oruka Therapeutics Inc — 2.41%
- Halozyme Therapeutics Inc — 2.30%
- Illumina Inc — 2.11%
- Alkermes Plc — 1.82%
- Viking Therapeutics Inc — 1.72%
- Roivant Sciences Ltd — 1.60%
- Neurocrine Biosciences Inc — 1.57%
- Arcus Biosciences Inc — 1.56%
- Zimmer Biomet Holdings Inc — 1.42%
Only in RYHIX
- Johnson & Johnson — 2.88%
- Thermo Fisher Scientific Inc — 1.61%
- Abbott Laboratories — 1.42%
- Cvs Health Corp — 1.31%
- Intuitive Surgical Inc — 1.31%
- Danaher Corp — 1.30%
- Bristol-myers Squibb Company — 1.22%
- Stryker Corp — 1.21%
- Mckesson Corp — 1.05%
- Cigna Group (the) — 0.94%
- Hca Healthcare Inc — 0.87%
- Cardinal Health Inc — 0.86%
- Edwards Lifesciences Corp — 0.84%
- Novo Nordisk A/s — 0.83%
Asset mix
| Asset type | DLHIX | RYHIX |
|---|---|---|
| Stocks | 94.8% | 83.2% |
| Preferred stock | 3.0% | — |
| Cash & short-term funds | 2.0% | — |
| Repurchase agreements | — | 0.9% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Country mix
| Country | DLHIX | RYHIX |
|---|---|---|
| US | 75.4% | 73.0% |
| BE | 5.2% | — |
| IE | 3.2% | 3.3% |
| GB | 3.3% | 1.8% |
| CH | 3.0% | 2.3% |
| JP | 2.8% | — |
| FR | 2.0% | — |
| NL | 1.6% | 0.7% |
Source: SEC Form N-PORT (periods Jun 30, 2026 / Jun 30, 2026)
Check another pair
FAQ
How much do DLHIX and RYHIX overlap?
What stocks do DLHIX and RYHIX have in common?
Should I own both DLHIX and RYHIX?
Which holds more stocks, DLHIX or RYHIX?
Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.